The DOI matches its Crossref record.
Hypoglycemia in the Diabetes Control and Complications Trial
Abstract
A total of 1,441 patients with IDDM were randomly assigned to receive either intensive (n = 711) or conventional (n = 730) diabetes therapy in the Diabetes Control and Complications Trial (DCCT). The patients were followed for an average of 6.5 years. Subjects were instructed to report all episodes of suspected severe hypoglycemia to their health care team. In addition, at quarterly follow-up visits, each subject was asked about the occurrence of severe hypoglycemia. There were 3,788 episodes of severe hypoglycemia (requiring assistance); 1,027 of these episodes were associated with coma and/or seizure. A total of 65% percent of patients in the intensive group vs. 35% of patients in the conventional group had at least one episode of severe hypoglycemia by the study end; the overall rates of severe hypoglycemia were 61.2 per 100 patient-years vs. 18.7 per 100 patient-years in the intensive and conventional treatment groups, respectively, with a relative risk (RR) of 3.28. The relative risk for coma and/or seizure was 3.02 for intensive therapy. The increased risk with intensive treatment persisted over each of the 9 years of follow-up in the DCCT and over the calendar years 1984–1993 during which the study was conducted. When baseline patient characteristics were examined for effects on the risk of severe hypoglycemia, the relative risk of hypoglycemia for intensive versus conventional treatment was ≥2 for all subgroups. Several subgroups defined by baseline characteristics, including males, adolescents, and subjects with no residual C-peptide or with a prior history of hypoglycemia, had a particularly high risk of severe hypoglycemia in both treatment groups. Analyses of the cumulative incidence of successive episodes indicated that intensive treatment was also associated with an increased risk of multiple episodes within the same patient (e.g., 22% experienced five or more episodes of severe hypoglycemia within the first 5 years of follow-up vs. 4% in the conventional group). Within both treatment groups, patients who experienced severe hypoglycemia were at increased risk of subsequent episodes. Approximately 30% of patients in each group experienced a second episode within the 4 months following the first episode of severe hypoglycemia. Within each treatment group, the number of prior episodes of hypoglycemia was the strongest predictor of the risk of future episodes, followed closely by the current HbA1c value. After adjustment for the current quarterly HbA1c level, intensive treatment was still associated with a significantly increased risk of hypoglycemia, indicating that the increased risk with intensive treatment is not completely explained by differences in HbA1c values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized controlled trials have established that intensive glycemic therapy prevents or delays the microvascular complications-retinopathy, nephropathy, and neuropathy-of diabetes (122, 123, 131, 144, 145), albeit at the expense of an increased frequency of hypoglycemia (117, 118, 122, 123, 132, 133, 144, 145).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [133]
In the citing paper
“A glucose of <70 mg/dL (3.9 mmol/L) is the classic threshold for hypoglycemia based on physiologic glucose regulation and neuroendocrine response in persons without DM.1197”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1197]
Citations
Cites
Still being checked.
Cited by
Items 301–400 of 779
Schober, E., Otto, K., Dost, A., Jorch, N., & Holl, R. W. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.09.054 · Cited by 39
A retrospective study on the incidence and risk factors of severe hypoglycemia in primary care
Sämann, A., Lehmann, T., Heller, T., Muller, N., Hartmann, P., Wolf, G., & Müller, U. (2012) · Family Practice · doi:10.1093/fampra/cms071 · Cited by 42
Current status and future of clinical islet xenotransplantation
Matsumoto, S., Tomiya, M., & Sawamoto, O. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12395 · Cited by 39
Bronstone, A. B., & Graham, C. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816633233 · Cited by 41
Karl, D. M., Philis‐Tsimikas, A., Darsow, T., Lorenzi, G. M., Kellmeyer, T., Lutz, K., Wang, Y., & Frías, J. P. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.0013 · Cited by 38
Reddy, M., & Oliver, N. S. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15504 · Cited by 47
Fear of hypoglycaemia and self-management in type 1 diabetes
Ahola, A. J., Saraheimo, M., Freese, R., Mäkimattila, S., Forsblom, C. M., & Groop, P. (2016) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2016.02.002 · Cited by 42
Hipoglicemia como fator complicador no tratamento do diabetes melito tipo 1
Nery, M. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000200016 · Cited by 52
Reliability of Trained Dogs to Alert to Hypoglycemia in Patients With Type 1 Diabetes
LOS, E. A., Ramsey, K., Guttmann‐Bauman, I., & Ahmann, A. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816666537 · Cited by 42
Glycemic Management in Adults With Type 1 Diabetes
McGibbon, A., Adams, L., Ingersoll, K. S., Kader, T., & Tugwell, B. D. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.012 · Cited by 58
Type 1 Diabetes TrialNet CTLA4-Ig (Abatacept) Study Group, Cabrera, S. M., Engle, S., Kaldunski, M. L., Jia, S., Geoffrey, R., Simpson, P. M., Szabó, A., Speake, C., Greenbaum, C. J., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4708-x · Cited by 38
Self-citationNateglinide - current and future role in the treatment of patients with type 2 diabetes mellitus
Campbell, I. W. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00669.x · Cited by 38
Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes
Home, P., Hallgren, P., Usadel, K. H., Sane, T., Faber, J. O., Grill, V., & Friberg, H. H. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.05.015 · Cited by 36
Carroll, M. F., Burge, M. R., & Schade, D. S. (2003) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1022990003161 · Cited by 47
Kovatchev, B. P., Lobo, B. J., Fabris, C., Ganji, M., Fathi, A. E., Breton, M. D., Kanapka, L. G., Kollman, C., Battelino, T., & Beck, R. W. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0404 · Cited by 37
Rankin, D., Cooke, D. D., Heller, S. R., Elliott, D., Amiel, S. A., & Lawton, J. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03670.x · Cited by 36
Oliver, N. S., Giménez, M., Calhoun, P. M., Cohen, N., Moscardó, V., Hermanns, N., Freckmann, G., Reddy, M., & Heinemann, L. (2019) · Diabetes Care · doi:10.2337/dc19-0977 · Cited by 39
Hassan, K., Rodríguez, L. M., Johnson, S. E., Tadlock, S., & Heptulla, R. A. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1679 · Cited by 38
Zammitt, N. N., Geddes, J., Warren, R. E., Marioni, R. E., Ashby, J. P., & Frier, B. M. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02263.x · Cited by 40
Malmgren, S., & Åhrén, B. (2015) · Diabetologia · doi:10.1007/s00125-015-3518-7 · Cited by 35
Clinical results of islet transplantation
Maffi, P., & Secchi, A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.04.010 · Cited by 36
Tkacs, N. C., & Levin, B. E. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00312.2004 · Cited by 34
Ito, M., Bujo, H., Takahashi, K., Arai, T., Tanaka, I., & Saito, Y. (2005) · Diabetologia · doi:10.1007/s00125-005-1825-0 · Cited by 34
Jannuzzi, F. F., Rodrigues, R. C. M., Cornélio, M. E., São‐João, T. M., & Gallani, M. C. B. J. (2014) · Revista Latino-Americana de Enfermagem · doi:10.1590/0104-1169.3578.2448 · Cited by 36
Waldron-Lynch, F., Kareclas, P., Kathryn, I., Walker, N. M., Mander, A., Wicker, L. S., Todd, J. A., & Bond, S. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005559 · Cited by 33
Hospitalization and Discharge Education of Emergency Department Patients With Hypoglycemia
Ginde, A. A., Pallin, D. J., & Camargo, C. A. (2008) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721708321022 · Cited by 33
From Bedside to Bench and Back Again: Research Issues in Animal Models of Human Disease
Tkacs, N. C., & Thompson, H. J. (2006) · Biological Research For Nursing · doi:10.1177/1099800406289717 · Cited by 37
Abitbol, L., & Palmert, M. R. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.08.098 · Cited by 32
Kovatchev, B. P. (2012) · Scientifica · doi:10.6064/2012/283821 · Cited by 39
García‐Casares, N., García-Arnés, J. A., Rioja, J., Ariza, M. J., Gutiérrez, A., Alfaro, F., Nabrozidis, A., González-Alegre, P., & González‐Santos, P. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.12.001 · Cited by 33
Rekittke, N. E., Ang, M., Rawat, D., Khatri, R., & Linn, T. (2016) · Stem Cells International · doi:10.1155/2016/3764681 · Cited by 41
Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2
Nowak, C., Lind, M., Šumník, Z., Pelikánová, T., Nattero‐Chávez, L., Lundberg, E., Rica, I., Martínez‐Brocca, M. A., de Adana, M. R., Wahlberg, J., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac343 · Cited by 39
Diabetes in the Emergency Department: Acute Care of Diabetes Patients
McNaughton, C. D., Self, W. H., & Slovis, C. M. (2011) · Clinical Diabetes · doi:10.2337/diaclin.29.2.51 · Cited by 36
Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy
Chakrabarti, S., Cukiernik, M., Hileeto, D., Evans, T., & Chen, S. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(0000)9999:9999<::aid-dmrr157>3.0.co;2-g · Cited by 97
McNay, E. C., Teske, J. A., Kotz, C. M., Dunn-Meynell, A., Levin, B. E., McCrimmon, R. J., & Sherwin, R. S. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00262.2012 · Cited by 31
Parsaik, A. K., Carter, R. E., Pattan, V., Myers, L. A., Kumar, H., Smith, S. A., Russi, C. S., Levine, J. A., Basu, A., & Kudva, Y. C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600109 · Cited by 33
Szepietowska, B., Zhu, W., Chan, O., Horblitt, A., Dziura, J., & Sherwin, R. S. (2011) · Diabetes · doi:10.2337/db11-0432 · Cited by 30
Intensive glucose control and hypoglycaemia: a new cardiovascular risk factor?
Rana, O. A., Byrne, C. D., & Greaves, K. (2013) · Heart · doi:10.1136/heartjnl-2013-303871 · Cited by 34
Eid, Y. M., Sahmoud, S. I., Abdelsalam, M., & Eichorst, B. (2017) · Diabetes Spectrum · doi:10.2337/ds15-0058 · Cited by 30
Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes
Dadlani, V., Pinsker, J. E., Dassau, E., & Kudva, Y. C. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1051-z · Cited by 32
Wood, M. A., Shulman, D. I., Forlenza, G. P., Bode, B. W., Pinhas‐Hamiel, O., Buckingham, B. A., Kaiserman, K. B., Liljenquist, D. R., Bailey, T. S., Shin, J., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0209 · Cited by 32
Cutruzzolà, A., Irace, C., Parise, M., Fiorentino, R., Tripodi, P. F. P., Ungaro, S., Babinsky, V. N., & Gnasso, A. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.06.009 · Cited by 32
Approach to Managing Hypoglycemia in Elderly Patients with Diabetes
Alagiakrishnan, K., & Mereu, L. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.05.2150 · Cited by 31
Jansà, M., Quirós, C., Giménez, M., Vidal, M., Galindo, M., & Conget, I. (2015) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2015.12.012 · Cited by 30
Muneer, M. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2020_534 · Cited by 28
Capel, I., Rigla, M., García-Sáez, G., Rodríguez-Herrero, A., Pons, B., Subías, D., García-García, F., Gallach, M., Aguilar, M., Gandía, C. P., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0229 · Cited by 36
Lammert, M., Hammer, M., & Frier, B. M. (2009) · Journal of Medical Economics · doi:10.3111/13696990903310501 · Cited by 30
Ishtiak‐Ahmed, K., Carstensen, B., Pedersen‐Bjergaard, U., & Jørgensen, M. E. (2016) · Diabetes Care · doi:10.2337/dc16-0862 · Cited by 30
Giménez, M., Tannen, A. J., Reddy, M., Moscardó, V., Conget, I., & Oliver, N. S. (2017) · Diabetes Care · doi:10.2337/dc17-1597 · Cited by 31
Dagogo-Jack, S. (2015) · Diabetes Care · doi:10.2337/dc15-0533 · Cited by 28
Joshi, M., & Choudhary, P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0644-z · Cited by 32
Initiating insulin in patients with type 2 diabetes
Lau, A. N. C., Tang, T., Halapy, H., Thorpe, K. E., & Yu, C. H. Y. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.110779 · Cited by 32
Blood Glucose Pattern Management in Diabetes: Creating Order from Disorder
Choudhary, P., Genovese, S., & Reach, G. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700618 · Cited by 30
Silva, T. P., Rolim, L. C., Filho, C. S., Zimmermann, L. M., Malerbi, F. K., & Dib, S. A. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2830 · Cited by 28
Evaluation of CGMS ® During Rapid Blood Glucose Changes in Patients with Type 1 Diabetes
Wilhelm, B., Forst, S., Weber, M. M., Larbig, M., Pfützner, A., & Forst, T. M. (2006) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.8.146 · Cited by 28
Takeshita, F., Kodama, M., Yamamoto, H., Ikarashi, Y., Ueda, S., Teratani, T., Yamamoto, Y., Tamatani, T., Kanegasaki, S., Ochiya, T., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0432-z · Cited by 28
Kähler, P., Grevstad, B., Almdal, T., Gluud, C. N., Wetterslev, J., Vaag, A. A., & Hemmingsen, B. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004806 · Cited by 35
Simon, D., de Pablos-Velasco, P. L., Parhofer, K. G., Gonder-Frederick, L. A., Duprat-Lomon, I., Vandenberghe, H., Eschwège, É., & Bradley, C. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.08.007 · Cited by 30
Speight, J., Barendse, S., Singh, H., Little, S. A., Rutter, M. K., Heller, S. R., & Shaw, J. (2014) · SAGE Open Medicine · doi:10.1177/2050312114527443 · Cited by 28
Salido, E. M., de Zavalía, N., Schreier, L. E., Laurentiis, A. D., Rettori, V., Chianelli, M. S., Sarmiento, M. I. K., Arias, P., & Rosenstein, R. E. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.04.010 · Cited by 27
Effect of insulin pen devices on the management of diabetes mellitus
Meece, J. D. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070524 · Cited by 27
Forlenza, G. P., Raghinaru, D., Cameron, F. M., Bequette, B. W., Chase, H. P., Wadwa, R. P., Maahs, D. M., Jost, E., Ly, T. T., Wilson, D. M., et al. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12603 · Cited by 28
Heller, S. R., Gianfrancesco, C., Taylor, C., & Elliott, J. (2020) · Diabetic Medicine · doi:10.1111/dme.14268 · Cited by 35
Schultes, B., Peters, A., Kern, W., Gais, S., Oltmanns, K. M., Fehm, H. L., & Jan Born, A. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.12.006 · Cited by 27
Bragd, J., Adamson, U., Lins, P. E., Wredling, R., & Oskarsson, P. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00902.x · Cited by 29
Ang, M., Meyer, C., Brendel, M. D., Bretzel, R. G., & Linn, T. (2013) · Diabetologia · doi:10.1007/s00125-013-3120-9 · Cited by 29
Smikhovskaia, A. V., Andrianov, V. S., Khairullina, E. M., Lebedev, D. V., Ryazantsev, M. N., Panov, M. S., & Tumkin, I. I. (2019) · Applied Surface Science · doi:10.1016/j.apsusc.2019.05.061 · Cited by 26
Pros and cons of continuous glucose monitoring in the intensive care unit
Sun, M.-T., Li, I.-C., Lin, W., & Lin, G. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i29.8666 · Cited by 27
Sreenan, S., Virkamäki, A., Zhang, K., Hansen, J. B., & on behalf of the PREDICTIVE™ study group (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01939.x · Cited by 25
Safety and side effects of the insulin analogues
Kamal, A. D., Dixon, A., & Bain, S. C. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.1.131 · Cited by 27
A Semilogarithmic Scale for Glucose Provides a Balanced View of Hyperglycemia and Hypoglycemia
Rodbard, D. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300620 · Cited by 26
Differential adaptation of neurocognitive brain functions to recurrent hypoglycemia in healthy men
Schultes, B., Kern, W., Oltmanns, K. M., Peters, A., Gais, S., Fehm, H. L., & Jan Born, A. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.06.007 · Cited by 27
Frequency, Causes and Risk Factors for Hypoglycaemia in Type 1 Diabetes
Strachan, M. W. J. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch4 · Cited by 27
Kumareswaran, K., Elleri, D., Allen, J. M., Harris, J. R., Xing, D., Kollman, C., Nodale, M., Murphy, H. R., Amiel, S. A., Heller, S. R., et al. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500606 · Cited by 31
Robertson, H., Pearson, D. W. M., & Gold, A. E. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02769.x · Cited by 25
Laubner, K., Molz, K., Kerner, W., Karges, W., Lang, W., Dapp, A., Schütt, M., Best, F., Seufert, J., & Holl, R. W. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2500 · Cited by 27
Bakhtiani, P. A., Youssef, J. E., Duell, A. K., Branigan, D. L., Jacobs, P. G., Lasarev, M. R., Castle, J. R., & Ward, W. K. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.09.001 · Cited by 28
Joshi, T., Oldmeadow, C. J., Attia, J., & Wynne, K. (2017) · Diabetic Medicine · doi:10.1111/dme.13337 · Cited by 26
Asymptomatic hypoglycaemia in Type 1 diabetes: incidence and risk factors
Henriksen, M. M., Andersen, H. U., Thorsteinsson, B., & Pedersen‐Bjergaard, U. (2018) · Diabetic Medicine · doi:10.1111/dme.13848 · Cited by 26
Kilpatrick, E. S., Rigby, A. S., Atkin, S. L., & Frier, B. M. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03612.x · Cited by 25
Acyl-ghrelin Is Permissive for the Normal Counterregulatory Response to Insulin-Induced Hypoglycemia
Shankar, K., Gupta, D., Mani, B. K., Findley, B. G., Lord, C. C., Osborne-Lawrence, S. L., Metzger, N. P., Pietra, C., Liu, C., Berglund, E. D., et al. (2019) · Diabetes · doi:10.2337/db19-0438 · Cited by 26
Amiel, S. A., Heller, S. R., Macdonald, I. A., Schwartz, S. L., Klaff, L. J., Ruggles, J. A., Weyer, C., Kolterman, O., & Maggs, D. G. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00417.x · Cited by 25
Protein-Based Biosensors for Diabetic Patients
Scognamiglio, V., Staiano, M., Rossi, M., & D’Auria, S. (2004) · Journal of Fluorescence · doi:10.1023/b:jofl.0000039337.30726.6d · Cited by 25
Brown, S. A., Basu, A., & Kovatchev, B. P. (2019) · Diabetic Medicine · doi:10.1111/dme.13944 · Cited by 27
Evolution of pancreas transplant surgery
Lam, V. W. T., Pleass, H. C. C., Hawthorne, W. J., & Allen, R. D. M. (2010) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2010.05309.x · Cited by 24
Pancreatic islet reserve in type 1 diabetes
Flatt, A. J., Greenbaum, C. J., Shaw, J., & Rickels, M. R. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14572 · Cited by 28
Sundberg, F., Nåtman, J., Franzén, S., Åkesson, K., & Särnblad, S. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13211 · Cited by 27
Asadi, F., & Dhanvantari, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.726368 · Cited by 28
Psychometric validation of the Hypoglycemia Fear Survey-II (HFS-II) in Singapore
Lam, A. Y. R., Xin, X., Tan, W. B., Gardner, D. S.-L., & Goh, S. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000329 · Cited by 28
How has psycho‐behavioural research advanced our understanding of hypoglycaemia in type 1 diabetes?
Hendrieckx, C., Gonder-Frederick, L. A., Heller, S. R., Snoek, F. J., & Speight, J. (2019) · Diabetic Medicine · doi:10.1111/dme.14205 · Cited by 25
Inouye, K., Chan, O. T. M., Yue, J. T. Y., Matthews, S. G., & Vranić, M. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00389.2004 · Cited by 29
Progress of artificial pancreas devices towards clinical use: the first outpatient studies
Russell, S. J. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000142 · Cited by 28
The closed‐loop artificial pancreas in 2020
Fabris, C., & Kovatchev, B. P. (2020) · Artificial Organs · doi:10.1111/aor.13704 · Cited by 24
Serné, E. H., Roze, S., Buompensiere, M. I., Valentine, W. J., de Portu, S., & de Valk, H. W. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02058-9 · Cited by 27
Yenigün, M., & Honka, M. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01973.x · Cited by 24
Clinically Accurate Prediction of Glucose Levels in Patients with Type 1 Diabetes
Amar, Y., Shilo, S., Oron, T., Amar, E., Phillip, M., & Segal, E. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0435 · Cited by 27
Prognosis of persons with type 1 diabetes on intensified insulin therapy in relation to nephropathy
Mühlhauser, I., Sawicki, P. T., Blank, M., Overmann, H., Bender, R., & Berger, M. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00745.x · Cited by 23
Matveyenko, A. V., Bohland, M., Saberi, M., & Donovan, C. M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00283.2007 · Cited by 22
Hartemann, A., Sachon, C., Massebœuf, N., Corset, E., & Grimaldi, A. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70007-1 · Cited by 24
Protective Effect of Insulin against Hypoglycemia-Associated Counterregulatory Failure
Fruehwald-Schultes, B., Kern, W., Deininger, E., Wellhoener, P., Kerner, W., Born, J., Fehm, H. L., & Peters, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1551 · Cited by 32
Metadata
- Authors
- The Diabetes Control and Complications Trial Research Group
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- The Diabetes Control and Complications Trial Research Group
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1997-02-01
- Volume
- 46
- Issue
- 2
- Pages
- 271-286
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W4252271922
- Semantic Scholar
- 0b14f6e58470afda31b2a9daa1c3fb61be7dad5a
- Cited by
- 746
- References
- 0
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 14 · 2023: 16 · 2022: 23 · 2021: 21 · 2020: 30 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 36 · 2015: 47 · 2014: 45 · 2013: 36 · 2012: 33
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- severe hypoglycemia, type 1 diabetes, intensive insulin therapy, baseline characteristics, Diabetes Control and Complications Trial, hypoglycemia risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.